James Stephen Farrelly

Title: Innovations of James Stephen Farrelly

Introduction

James Stephen Farrelly is a notable inventor based in Milford, Connecticut. He has made significant contributions to the field of medical science, particularly in the area of fetal medicine. His innovative work focuses on the delivery of active agents in utero, which has the potential to improve outcomes for unborn children.

Latest Patents

Farrelly holds a patent for "Compositions and methods for in utero delivery." This patent describes compositions and methods for the fetal or in utero delivery of active agents. The compositions are typically administered intravenously via the vitelline vein, umbilical vein, or directly into the amniotic cavity of a pregnant mother. One of the key components of his invention is the use of fibroblast growth factor to correct structural defects of neural tissue. He has 1 patent to his name.

Career Highlights

James Stephen Farrelly is affiliated with Yale University, where he continues to engage in groundbreaking research. His work at this prestigious institution allows him to collaborate with other leading experts in the field, further enhancing the impact of his inventions.

Collaborations

Farrelly has worked alongside notable colleagues such as W Mark Saltzman and David H Stitelman. These collaborations have contributed to the advancement of his research and the development of innovative solutions in fetal medicine.

Conclusion

James Stephen Farrelly's contributions to the field of in utero delivery represent a significant advancement in medical science. His innovative approaches have the potential to improve the health and well-being of unborn children.